Suppr超能文献

北欧原发性肝癌和胰腺癌的长期生存趋势。

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries.

作者信息

Hemminki Kari, Försti Asta, Hemminki Otto, Liska Vaclav, Hemminki Akseli

机构信息

Biomedical Center, Faculty of Medicine, Charles University, Pilsen, Czech Republic.

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

出版信息

JHEP Rep. 2022 Sep 29;4(12):100602. doi: 10.1016/j.jhepr.2022.100602. eCollection 2022 Dec.

Abstract

BACKGROUND & AIMS: Liver cancer (LC) and pancreatic cancer (PC) are often diagnosed at an advanced stage resulting in high mortality. High-quality survival data are rarely available for trend analyses over a long period.

METHODS

The Danish, Finnish, Norwegian, and Swedish cancer data were accessed at the NORDCAN database. We analysed relative 1- and 5-year survival trends in LC and PC between years 1970 and 2019.

RESULTS

Relative 1-year survival in LC for Nordic men and women was about 10% in the period between 1970 and 1974, and it increased moderately by year 2000 and steeply thereafter, eventually reaching 40-50%. The patterns in 5-year survival were similar, but after the year 2000, survival in Norway and Sweden increased steeply to 23%, whereas survival in Denmark and Finland lagged behind, reaching 10% to 15%. The patterns for PC also showed rapid improvement after the year 2000, with 1-year survival reaching 30% to 40% and 5-year survival reaching 10% for Finland and 15% for Norway and Sweden. Survival was best for patients diagnosed before age 50 years, and it was worst for older patients. For both cancers the difference between 1- and 5-year survival increased with time.

CONCLUSIONS

Survival in LC and PC improved first modestly and then steeply over the 50-year period covered. The increase in 5-year survival was less than that of 1-year survival. The survival gains were most likely the result of earlier diagnosis, improved treatment, and better organised supportive care. The challenges are to keep up these positive trends, to extend survival benefits past Year 1, and to obtain similar results in elderly patients. Primary prevention through avoidance of risk factors would reduce case numbers.

LAY SUMMARY

Liver and pancreatic cancers are among the most lethal of all cancers. In 50 years, survival in these cancers has slowly improved, and in the past 20 years, the development has been increasingly favourable. Widespread adoption of healthy lifestyles will be key to reducing the risk of these cancers.

摘要

背景与目的

肝癌(LC)和胰腺癌(PC)通常在晚期才被诊断出来,导致死亡率很高。长期趋势分析很少有高质量的生存数据。

方法

在北欧癌症数据库(NORDCAN)中获取丹麦、芬兰、挪威和瑞典的癌症数据。我们分析了1970年至2019年期间肝癌和胰腺癌的1年和5年相对生存趋势。

结果

1970年至1974年期间,北欧男性和女性肝癌的1年相对生存率约为10%,到2000年适度上升,此后急剧上升,最终达到40%-50%。5年生存率的模式相似,但2000年后,挪威和瑞典的生存率急剧上升至23%,而丹麦和芬兰的生存率则滞后,达到10%-15%。胰腺癌的模式在2000年后也显示出快速改善,芬兰的1年生存率达到30%-40%,挪威和瑞典的5年生存率达到10%,芬兰为15%。50岁前诊断出的患者生存率最佳,老年患者生存率最差。对于这两种癌症,1年和5年生存率之间的差异随时间增加。

结论

在涵盖的50年期间,肝癌和胰腺癌的生存率首先适度提高,然后急剧提高。5年生存率的提高低于1年生存率。生存率的提高很可能是早期诊断、治疗改善和组织更好的支持性护理的结果。挑战在于保持这些积极趋势,将生存益处延长到1年以后,并在老年患者中取得类似结果。通过避免风险因素进行一级预防将减少病例数。

简要概述

肝癌和胰腺癌是所有癌症中最致命的癌症之一。在50年里,这些癌症的生存率缓慢提高,在过去20年里,发展趋势越来越有利。广泛采用健康的生活方式将是降低这些癌症风险的关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2316/9638835/46c4c005e5e7/ga1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验